Worldwide Biomedical Photoacoustic Imaging Patent Landscape Report 2015

News provided by

Jul 07, 2015, 10:44 ET

DUBLIN, June 30, 2015 /PRNewswire/ --

Research and Markets(http://www.researchandmarkets.com/research/mbgs4b/biomedical) has announced the addition of the "Biomedical Photoacoustic Imaging Patent Landscape" report to their offering.

This patent landscape focuses on photoacoustic imaging in biomedicine. Photoacoustic imaging is a safe, non-invasive, non-ionizing imaging technique. The technique offers several advantages and represents a great alternative to traditional medical imaging approaches. The innovation of photoacoustic imaging for biomedical purposes is mainly driven by the need to enhance the efficiency of the detection and diagnostic of cancer. The photoacoustic imaging technologies involve more than 100 different applicants and more than 900 patent families related to photoacoustic imaging have been published worldwide up to January 2015.

In the early 80s, the University of Arizona published the 1st patent transposing photoacoustic technology to biomedical imaging. But the technology only really emerged in 1997, especially after the publication of the patent introducing a time factor to the technology and thus allowing a three dimensional image reconstruction. Since 2010, a take off in the number of new applications is observed, indicating a strong and growing interest for the use of photoacoustic in imaging techniques. Photoacoustic imaging is a very promising technique for the medical field, especially for diagnostic and treatment cancers, and offers many advantages such as safety, great resolution, easy-to-use and low cost. Thus the number of new patent applications in the domain is expected to keep rising.

Key Features Of The Report:

The report provides essential patent data for biomedical photoacoustic imaging including:
-Time evolution of patent publications and countries of patent filings.
-Current legal status of patents.
-Ranking of main patent applicants.
-Joint developments and IP collaboration network of main patent applicants.
-Key patents.
-Granted patents near expiration.
-Relative strength of main companies IP portfolio.
-Photoacoustic imaging IP profiles of 15 major companies with key patents, partnerships, and IP strength and strategy.

Objective Of The Report:

- Understand the IP landscape for biomedical photoacoustic imaging.
- Identify key patents.
- Understand trends in biomedical photoacoustic imaging IP.
- Classify the major players in biomedical photoacoustic imaging IP and the relative strength of their patent portfolio.
- Identify new players in biomedical photoacoustic imaging IP.
- Identify IP collaboration networks between key players.

Key Topics Covered:

1. Introduction

Authors
Scope of the Report
Key Features of the Report
Objectives of the Report
Terminology for Patent Analysis
Methodology
Patent Search Strategy
Assignees Mentioned in this Report

2. Executive Summary

3. Photoacoustic Imaging Patent Landscape Overview

Time Evolution of Patent Publications
Countries of Patent Filings
Time Evolution by Country of Filing
Current Legal Status of Patents
Main Industrial Patent Applicants Ranking
Main Academic Patent Applicants Ranking
Time Evolution of Patent Applicants
Countries of Filing for Main Patent Applicants
Mapping of Main Current IP Holders
Mapping of Main Current IP Applicants
Main IPC Classes
Time Evolution by IPC
Matrix Applicants / Main IPC
Patented Technology by Products
Patented Technology by Applications
Summary of Applicant's Patent Portfolio
Leadership of Patent Applicants
Degree of Specialization in Photoacoustic imaging
Impact Factor of Patent Portfolios
IP Blocking Potential of Applicants
Patent Applicant IP Network
Key Patent Families
Granted Patents Near Expiration
Potential Future Plaintiffs

4. Summary of Key Players

Canon
Fujifilm
Fujifilm VisualSonics
Seno Medical Instruments
Philips
Volcano
Covidien
Mallinckrodt Pharmaceuticals
Samsung
ENDRA Life Sciences
TomoWave Laboratories
National Institutes of Health
University of Texas
Helmholtz Zentrum München
South China Normal University
Jiangxi Sciences & Technic Normal University
Shenzhen Institute of Advanced Technology

5. Conclusions

6. Annexes

Methodology for Key Patent Identification

Companies Mentioned

- Canon
- Covidien
- ENDRA Life Sciences
- Fujifilm
- Helmholtz Zentrum München
- Jiangxi Sciences & Technic Normal University
- Mallinckrodt
- NIH
- OptoSonics
- Philips
- Samsung
- Seno Medical Instruments
- Shenzhen Institute of Advanced Technology
- South China Normal University
- TomoWave Laboratories
- University of Texas
- VisualSonics
- Volcano

For more information visit http://www.researchandmarkets.com/research/mbgs4b/biomedical